clinical trials

Incyte reports positive data from Phase III vitiligo trial
Incyte reports positive data from Phase III vitiligo trial
Clinical Trials Arena
Incyte
Opzelura
vitiligo
clinical trials
Flag link:
FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says
FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says
Reuters
Pfizer
clinical trials
Lyme disease
Valneva
vaccines
FDA
Flag link:
AbbVie’s Rinvoq shows long-term sustained efficacy in atopic dermatitis
AbbVie’s Rinvoq shows long-term sustained efficacy in atopic dermatitis
Clinical Trials Arena
AbbVie
clinical trials
Rinvoq
atopic dermatitis
Flag link:
Israel prepared to keep clinical trials running during war
Israel prepared to keep clinical trials running during war
Clinical Trials Arena
Israel
clinical trials
Flag link:
Merck KGaA, with hold still clouding prospects, guides MS drug past durability test ahead of phase 3 data
Merck KGaA, with hold still clouding prospects, guides MS drug past durability test ahead of phase 3 data
Fierce Biotech
Merck KGaA
evobrutinib
MS
multiple sclerosis
clinical trials
Flag link:
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
BioSpace
Novo Nordisk
semaglutide
clinical trials
diabetes
chronic kidney disease
Flag link:
Roche preps for filings after subcutaneous Ocrevus matches up to IV formulation in phase 3 study
Roche preps for filings after subcutaneous Ocrevus matches up to IV formulation in phase 3 study
Fierce Pharma
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
Flag link:
Faron’s Clever-1 drug shows promise in blood cancers
Faron’s Clever-1 drug shows promise in blood cancers
Pharmaphorum
Faron Pharmaceuticals
bexmarilimab
AML
MDS
clinical trials
Flag link:
Xenon’s Add-On Epilepsy Treatment Shows Promising Phase IIb Efficacy, Safety
Xenon’s Add-On Epilepsy Treatment Shows Promising Phase IIb Efficacy, Safety
BioSpace
Xenon
epilepsy
clinical trials
XEN1101
Flag link:
Newron's Schizophrenia Candidate Scores Mid-Stage Win, Moves to Phase III
Newron's Schizophrenia Candidate Scores Mid-Stage Win, Moves to Phase III
BioSpace
Newron Pharma
clinical trials
evenamide
schizophrenia
Flag link:
Akero's stock sinks as midphase cirrhosis fail sparks flash NASH crash
Akero's stock sinks as midphase cirrhosis fail sparks flash NASH crash
Fierce Biotech
Akero Therapeutics
NASH
efruxifermin
clinical trials
Flag link:
Ventyx Biosciences reports data from ulcerative colitis drug trial
Ventyx Biosciences reports data from ulcerative colitis drug trial
Clinical Trials Arena
Ventyx Biosciences
ulcerative colitis
VTX002
clinical trials
Flag link:
Chasing Boehringer, Anaptys hits goal in pivotal rare skin disease trial, plans out-licensing deal
Chasing Boehringer, Anaptys hits goal in pivotal rare skin disease trial, plans out-licensing deal
Fierce Biotech
AnaptysBio
generalized pustular psoriasis
clinical trials
imsidolimab
Boehringer Ingelheim
Flag link:
FDA grants Trascenta clearance for Phase III trial of Osemitamab
FDA grants Trascenta clearance for Phase III trial of Osemitamab
Clinical Trials Arena
Osemitamab
gastic cancer
Trascenta
clinical trials
Flag link:
Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials
Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials
Drugs.com
Paradigm Health
Bristol Myers Squibb
clinical trials
Flag link:
Longeveron's Alzheimer's Candidate Meets Safety Goal In Mid-Stage Study
Longeveron's Alzheimer's Candidate Meets Safety Goal In Mid-Stage Study
Benzinga
Longeveron
clinical trials
Alzheimer's disease
lomacel-B
Flag link:
Boehringer moves obesity therapy into phase 3
Boehringer moves obesity therapy into phase 3
Pharmaphorum
Boehringer Ingelheim
Zealand Pharma
clinical trials
obesity
survodutide
Flag link:
FDA adcomm backs US WorldMeds’ potential high-risk pediatric neuroblastoma drug
FDA adcomm backs US WorldMeds’ potential high-risk pediatric neuroblastoma drug
Medical Marketing and Media
US WorldMeds
FDA
pediatric neuroblastoma
clinical trials
eflornithine
Flag link:
J&J’s Spravato Bests Quetiapine in Phase III Head-to-Head Depression Study
J&J’s Spravato Bests Quetiapine in Phase III Head-to-Head Depression Study
BioSpace
JNJ
clinical trials
Spravato
treatment-resistant depression
depression
Quetiapine
Flag link:
Neurocrine's pediatric phase 3 data are missing piece of puzzle for hyperplasia drug submission
Neurocrine's pediatric phase 3 data are missing piece of puzzle for hyperplasia drug submission
Fierce Biotech
Neurocrine
hyperplasia
clinical trials
Flag link:

Pages